ライフサイエンスコーパス: Escherichia

1 m (VREfc/VREfm), and ciprofloxacin-resistant Escherichia coli (CipREc) colonization.

2 and DNA gap repair typically involve growing Escherichia coli (E coli) containing plasmids, followed

3 ofiles of sites of unsaturation of lipids in Escherichia coli (E. coli) and Acinetobacter baumannii (

4 vestigated the inactivation of Gram-negative Escherichia coli (E. coli) and Gram-positive Enterococcu

5 sed using the inhibition zone method against Escherichia coli (E. coli) and Staphylococcus aureus (S.

6 an in vivo assessment platform comprised of Escherichia coli (E. coli) and transgenic zebrafish embr

7 demonstrate rapid, sensitive and label-free Escherichia coli (E. coli) detection utilizing interfero

8 IEF-MS/MS identified 711 proteoforms from an Escherichia coli (E. coli) proteome consuming only nanog

9 Most Escherichia coli (E. coli) strains do not cause disease,

10 Escherichia coli (E. coli) was engineered to catalyse th

11 Interacting Protein (DIP) Human, Drosophila, Escherichia coli (E. coli), and Caenorhabditis elegans (

12 xides that in the dark inactivate planktonic Escherichia coli (E. coli).

13 modelling (FBA, pFBA, FVA and MOMA) and the Escherichia coli (E.coli) core stoichiometric model to i

14 Enteroaggregative Escherichia coli (EAEC) is an E. coli pathotype associat

15 ith the diarrheal pathogen enteroaggregative Escherichia coli (EAEC) is associated with growth falter

16 days after beginning treatment, cultured for Escherichia coli (EC) and DNA extracted.

17 In enterohemorrhagic Escherichia coli (EHEC) O157:H7, EutR responds to ethano

18 Diarrheagenic Escherichia coli (enteroaggretative, enteropathogenic),

19 Enterotoxigenic Escherichia coli (ETEC) cause acute secretory diarrhoea

20 Enterotoxigenic Escherichia coli (ETEC) is a leading diarrheagenic bacte

21 Recent efforts to develop an enterotoxigenic Escherichia coli (ETEC) vaccine have focused on the anti

22 Extraintestinal pathogenic Escherichia coli (ExPEC) is the leading cause in humans

23 Injection of non-uropathogenic Escherichia coli (MG1655 strain) or phosphate-buffered s

24 -R assay in Klebsiella pneumoniae (n = 236), Escherichia coli (n = 22), Enterobacter cloacae (n = 23)

25 he family Enterobacteriaceae (p = 0.002) and Escherichia coli (p = 0.033).

26 tors for previously characterized viruses of Escherichia coli (phages T6, T2, T4, and T7).

27 Shiga-toxigenic Escherichia coli (STEC) infection causes severe bloody d

28 ssociated outbreaks of Shiga toxin-producing Escherichia coli (STEC) were first identified in 1991.

29 es are caused by Gram-negative uropathogenic Escherichia coli (UPEC) or Gram-positive Enterococcus fa

30 remove established biofilms of uropathogenic Escherichia coli (UPEC), Pseudomonas aeruginosa, and Sta

31 t infections (rUTIs) linked to uropathogenic Escherichia coli (UPEC).

32 fA, suppresses protein synthesis by immature Escherichia coli 30S subunits.

33 ectron microscopy (cryo-EM) structure of the Escherichia coli 50S subunit at an average resolution of

34 To better understand how Escherichia coli acclimatizes to nutrient availability,

35 nesis in tobacco correlated with assembly in Escherichia coli advocating use of this bacterium to pre

36 munized camel and purified the antibody from Escherichia coli after refolding it from inclusion bodie

37 interest in the structure and specificity of Escherichia coli AlkB and its homologs, difficulties in

38 oea associated with typical enteropathogenic Escherichia coli among children aged 6-11 months was 2.0

39 usters between 15 diverse species (including Escherichia coli and 12 rhizobia) help identify the barr

40 proposed SEF-AuNI sensors for model bacteria Escherichia coli and Bacillus subtilis can go to 0.5119

41 esent BEs that cause C-to-A transversions in Escherichia coli and C-to-G transversions in mammalian c

42 psis thaliana, Schizosaccharomyces pombe and Escherichia coli and how it can be used to study RBP dyn

43 Using tREX, we test 243 candidate tRNAs in Escherichia coli and identify 71 orthogonal tRNAs, cover

44 Es to induce Cas9-independent deamination in Escherichia coli and in human cells.

45 stinct plasmids in communities consisting of Escherichia coli and Klebsiella pneumoniae once antibiot

46 Enterococcus spp., Escherichia coli and Klebsiella pneumoniae were the comm

47 A phenotype of Escherichia coli and Klebsiella pneumoniae, resistant to

48 zer or Trimo-San) on growth and viability of Escherichia coli and Lactobacillus crispatus.

49 eria strains (including carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcu

50 nce-specific killing of carbapenem-resistant Escherichia coli and methicillin-resistant Staphylococcu

51 ic model of the fatty acid synthase (FAS) of Escherichia coli and paired that model with a fully reco

52 rs of the family, the transporters AmtB from Escherichia coli and Rh50 from Nitrosomonas europaea.

53 d BSA [AcBSA], zymosan, mannan, and LPS from Escherichia coli and Salmonella as well as to the monosa

54 The human bacterial pathogens Escherichia coli and Salmonella enterica produce a biofi

55 Studies in Escherichia coli and Salmonella enterica showed that suc

56 Our previous work in Escherichia coli and Salmonella identified a mechanism o

57 factors and their target genes in pathogenic Escherichia coli and Salmonella revealed using chromatin

58 gle-cell lag times of populations of starved Escherichia coli and show that population growth after s

59 ines following heterologous stimulation with Escherichia coli and Streptococcus pneumoniae.

60 luble chemical, 1-octanol, were evaluated in Escherichia coli and Synechocystis sp. PCC 6803.

61 wo live bacterial strains: the Gram-negative Escherichia coli and the Gram-positive Bacillus subtilis

62 hese proteins were produced recombinantly in Escherichia coli and used as antigens in phage display s

63 n of the sensor surface with polyclonal anti-Escherichia coli antibody allow to obtain high detection

64 es of the compounds against efflux-deficient Escherichia coli are mediated by LpxA inhibition.

65 positive Bacillus subtilis and Gram-negative Escherichia coli as model organisms to monitor bacterial

66 The stability of the Escherichia coli beta-clamp, a homodimer, is particularl

67 tenot et al. now show that Fur purified from Escherichia coli binds an all-Cys-coordinated [2Fe-2S] c

68 The M. smegmatis Tam functionally replaced Escherichia coli BioC both in vivo and in vitro.

69 Four candidate genes were overexpressed in Escherichia coli BL21(DE3), refolded, and purified.

70 demonstrated Gram-negative activity against Escherichia coli BW25113, which is the first reported fo

71 dly, myristoylation efficiency of MA(NOS) in Escherichia coli by co-expressed mammalian NMT was reduc

72 in diameter) in the industrial microorganism Escherichia coli by expressing a set of carboxysome prot

73 on with the enteric pathogen enterotoxigenic Escherichia coli by maternal natural IgG antibodies agai

74 at its depletion attenuates the virulence of Escherichia coli by reducing levels of LPS and outer mem

75 We apply the approach to Escherichia coli by successively adapting it to defined

76 e that coordination is indirect, mediated in Escherichia coli by the alarmone (p)ppGpp.

77 Escherichia coli can carry the pathogenicity island pks,

78 ation factor antigen I (CFA/I) fimbriae from Escherichia coli can inhibit autoimmune diseases in muri

79 Escherichia coli can utilize citrate under anaerobic con

80 Mutant Escherichia coli carrying this mutation are viable and h

81 Global N-acetylome profiling of Escherichia coli cells expressing AtNAA50 revealed conse

82 cally active recombinant hGFAT2 (rhGFAT2) in Escherichia coli cells fused or not to a HisTag at the C

83 Escherichia coli cells have a reversible rotary motor at

84 m of genetically modified Rosetta-gami B DE3 Escherichia coli cells, facilitating high-yield producti

85 ngle-cell measurements, we find that in live Escherichia coli cells, Zur's unbinding rate from DNA is

86 how these lesions impact DNA replication in Escherichia coli cells.

87 We examine two novel members of the Escherichia coli chaperone holdase family, RidA and CnoX

88 Phosphorylation of Escherichia coli CheY protein transduces chemoreceptor s

89 and regulation, primarily for the human and Escherichia coli class Ia enzymes.

90 microscopy (cryo-EM) structures of an intact Escherichia coli class-II CAP-dependent transcription ac

91 ined high-resolution structures of wild-type Escherichia coli ClpAP undergoing active substrate unfol

92 to three published examples of multi-strain Escherichia coli communities with increasing complexity:

93 Enteropathogenic and enterohemorrhagic Escherichia coli contain a well-defined T3SS but in addi

94 he remaining microimplants were incubated in Escherichia coli culture.

95 'gold-standard' is represented by infecting Escherichia coli cultures, followed by precipitation wit

96 Here we show that Escherichia coli DeltabipA cells grown at suboptimal tem

97 Escherichia coli DeltaL YA, in which lacZ is deleted and

98 gulation of gene expression by small RNAs in Escherichia coli depends on RNA binding proteins Hfq and

99 In addition, deletion of TrkA in Escherichia coli depolarizes the cell, suggesting that t

100 Here, we show that Pal accumulation at Escherichia coli division sites is a consequence of thre

101 hering of a protein of interest (POI) to the Escherichia coli DNA adenine methyltransferase (Dam).

102 entapeptide motif toward the beta subunit of Escherichia coli DNA polymerase III holoenzyme by mutati

103 Several functions have been proposed for the Escherichia coli DNA polymerase IV (pol IV).

104 We present the NMR solution structure for Escherichia coli DolP, which is composed of two BON doma

105 otypic multidrug (Mdr) transporter MdfA from Escherichia coli efflux chemically- dissimilar substrate

106 These observations were analogous to how Escherichia coli encountering cell stress and nutrient d

107 To address these challenges, we show that Escherichia coli Endonuclease V (eEndoV), an inosine-cle

108 pathogens such as Neisseria meningitidis and Escherichia coli express acidic capsules.

109 ter-membrane porin (omp)-deficient strain of Escherichia coli expressing heterologous VcChiP could gr

110 Unexpectedly, strains of Escherichia coli expressing this artificial protein spec

111 Escherichia coli FadR is a transcription factor regulate

112 Here, we use the Escherichia coli FAS AT, FabD, and its cognate ACP, AcpP

113 Here we show that damage-induced Escherichia coli filaments divide asymmetrically, produc

114 prisingly, recent single-cell experiments in Escherichia coli flagellar synthesis showed that flagell

115 e report the structure of the BAM complex of Escherichia coli folding BamA itself.

116 ic diversity of colistin-resistant commensal Escherichia coli from broiler chickens.

117 no acid sequence identity, were expressed in Escherichia coli Functional characterization of the puri

118 Purified prodigiosin and ShlA from Escherichia coli further supported the role of these fac

119 In this work, we express the Escherichia coli gene mreB inside vesicles with bilayers

120 fied evolutionarily conserved rare codons in Escherichia coli genes and associated such codons with c

121 aureus, 456 Pseudomonas aeruginosa, and 1588 Escherichia coli genomes.

122 , DNA-wrapping domain of the GyrA subunit of Escherichia coli gyrase (the 'CTD').

123 he authors describe an elegant strategy that Escherichia coli has evolved to minimize metabolic stres

124 ol-Pal components to the cytokinetic ring in Escherichia coli has led to the proposal that the primar

125 ere, we present the crystal structure of the Escherichia coli Hfq Core bound to a 30 bp DNA, containi

126 itro impair P2 OLD-mediated killing of recBC-Escherichia coli hosts, indicating that both the ATPase

127 haride (LPS) and the Gram-negative bacterium Escherichia coli However, the physiological roles of TCP

128 microfluidic device to study thermotaxis of Escherichia coli in a broad range of thermal gradients w

129 tress, and contributes to gene expression in Escherichia coli In addition, Q8 was proposed to confer

130 th the prevalence of ciprofloxacin-resistant Escherichia coli in cattle and to determine if removal o

131 In 2015, the mcr-1 gene was discovered in Escherichia coli in domestic swine in China that conferr

132 ull-length human FMRP, FXR1P, and FXR2P from Escherichia coli in high yields, free of protein and nuc

133 Escherichia coli is a pathogen commonly encountered in c

134 MdfA from Escherichia coli is a prototypical H(+) -dependent multi

135 Enterohemorrhagic Escherichia coli is a significant human pathogen that ca

136 Escherichia coli is an important model organism in micro

137 factor of human pathogenic enterohemorrhagic Escherichia coli is Shiga toxin (Stx).

138 Escherichia coli is the leading cause of urinary tract i

139 hesis machinery responsible for rod shape in Escherichia coli is the processive 'Rod complex'.

140 ded-spectrum beta-lactamase (ESBL)-producing Escherichia coli is worrisome.

141 ned priority AMR phenotypes and genotypes of Escherichia coli isolated from the gastrointestinal trac

142 Up to 48 presumptive Escherichia coli isolates were collected from each stool

143 ached the genome-scale in the widely studied Escherichia coli K-12 MG1655 strain.

144 g Synechococcus elongatus with heterotrophic Escherichia coli K-12, Escherichia coli W, Yarrowia lipo

145 zed 48 RIBO-Seq samples from nine studies of Escherichia coli K12 grown in lysogeny broth medium and

146 odification genes in model organisms such as Escherichia coli K12.

147 reference for transcriptional regulation in Escherichia coli K12.

148 mon alkylating agents to growing cultures of Escherichia coli leads to the accumulation of several ad

149 ssing three enzymes (almA, xylE, p450cam) in Escherichia coli led to degradation of 60-99% of target

150 necrosis factor-alpha (TNF-alpha), IL-1beta, Escherichia coli lipopolysaccharide (Ec-LPS) and Porphyr

151 We studied Escherichia coli LPS in patients with biopsy-proven NAFL

152 In NAFLD, Escherichia coli LPS may increase liver damage by induci

153 ous crystallographic studies have shown that Escherichia coli McrB uses a base-flipping mechanism to

154 Here we determine cryo-EM structures of Escherichia coli MlaFEDB in an apo state and bound to ph

155 ction is favored for C. crescentus MreB over Escherichia coli MreB because of a closer match in the d

156 s in the translation initiation step of many Escherichia coli mRNAs, particularly those with weak Shi

157 ct substrate is especially difficult for the Escherichia coli Nudix hydrolase RppH, which triggers 5'

158 The genome of Escherichia coli O157:H7 bacteriophage vB_EcoM_CBA120 en

159 aT2 toxin from a toxin-antitoxin system from Escherichia coli O157:H7.

160 iocin ColE9 is imported passively across the Escherichia coli OM through OmpF.

161 , breakpoints have been established only for Escherichia coli or Enterobacterales per the Clinical an

162 ally in classical bacteriophages that infect Escherichia coli or Salmonella, yet, less is known about

163 cal ligation and puncture or bacteremia with Escherichia coli or Streptococcus pneumoniae infection).

164 caecal ligation and puncture or infection by Escherichia coli or Streptococcus pneumoniae) and endoto

165 The Escherichia coli outer membrane receptor FepA transports

166 ve peptidoglycan precursors and fragments by Escherichia coli PBP1B, allowing us to (a) identify reco

167 19)F-(19)F nuclear Overhauser effects in the Escherichia coli peptidyl-prolyl cis/trans-isomerase B f

168 erminal domain is toxic when targeted to the Escherichia coli periplasm and that it depolarizes the c

169 r, we made the surprising discovery that the Escherichia coli periplasmic glycerol-3-phosphate (G3P)-

170 ng 10,000 compounds directly for stimulating Escherichia coli persister cell resuscitation, we identi

171 characterize host dependencies of two novel Escherichia coli phages, the T1-like siphophage LL5 and

172 bic growth on citrate (Cit(+)) evolved in an Escherichia coli population during adaptation to a minim

173 he "escape time" required for drug-resistant Escherichia coli populations to eclipse a threshold dens

174 eveal that colonization with curli-producing Escherichia coli promotes alphaSyn pathology in the gut

175 Here, we identify the uncharacterized Escherichia coli protein YcaQ as an ICL repair glycosyla

176 ntional 'on-bead' approach, we reconstituted Escherichia coli proteins MsbA and MscS and find that pe

177 ion sensitivity on various concentrations of Escherichia coli reaching 10(3) CFU/ml.

178 The synthetic capability of the Escherichia coli ribosome has attracted efforts to repur

179 ilarly affect both the efficiency with which Escherichia coli RNA polymerase incorporates dinucleosid

180 to visualize seven intermediates containing Escherichia coli RNAP with the transcription factor TraR

181 , can stimulate translesion RNA synthesis by Escherichia coli RNAP without altering the fidelity of n

182 emical approach for halting transcription by Escherichia coli RNAP.

183 one due to neutropenic sepsis and one due to Escherichia coli sepsis), each in the setting of progres

184 Escherichia coli serogroups O157, O26, O45, O103, O111,

185 ons of increased chromosome occupancy of the Escherichia coli SMC complex, MukBEF, the chromosome is

186 Here we show that the Escherichia coli SSB protein forms liquid-liquid phase-s

187 scent domains are inserted within the IDL of Escherichia coli SSB.

188 tibody (mAb) targeting the O25b O-antigen of Escherichia coli ST131.

189 When expressed in an Escherichia coli strain deficient in sulfite assimilatio

190 Here we introduce an Escherichia coli strain that forms small minicells posse

191 rowth of the C. elegans dynamin mutant on an Escherichia coli strain with low vitamin B12 also strong

192 of febrile UTI is often caused by a virulent Escherichia coli strain, whereas recurrent infections an

193 e double-stranded DNA phages using two model Escherichia coli strains (K-12 and BL21) with known sequ

194 in vivo k (cat)s using metabolic specialist Escherichia coli strains that resulted from gene knockou

195 A library of recombinant non-pathogenic Escherichia coli strains was engineered to express seven

196 ation-enabled large-scale experiment wherein Escherichia coli strains were evolved in parallel after

197 rmine the antibiotic dose-response curves of Escherichia coli strains, and previous observations on a

198 Cross-feeding Escherichia coli strains, where one strain feeds on a ca

199 t of adhesive type 1 pili from uropathogenic Escherichia coli strains.

200 sate consisting of heat-killed Gram-negative Escherichia coli Symbio and Gram-positive Enterococcus f

201 fitness effects of missense mutations in the Escherichia coli TEM-1 beta-lactamase antibiotic resista

202 a high-flux diffusive pathway for PL flow in Escherichia coli that is modulated by YhdP.

203 n-mucin stain derived from enterohemorrhagic Escherichia coli that is tolerant to a wide range of gly

204 MinD is a cell division ATPase in Escherichia coli that oscillates from pole to pole and r

205 It has been proposed that in Escherichia coli the component of cytochrome bd-I termin

206 ve bioprocess using metabolically engineered Escherichia coli The pretreatment step achieved an almos

207 scharging is not known to occur in bacteria, Escherichia coli ThrRS also possesses robust cross-editi

208 Thymineless death in Escherichia coli thyA mutants growing in the absence of

209 We show utilization hierarchy of Escherichia coli to be ordered by the carbon-uptake flux

210 n most studied species and R1-R2 octamers in Escherichia coli To better understand the distribution o

211 The attractant chemotaxis response of Escherichia coli to norepinephrine requires that it be c

212 d a two-color fluorescence reporter assay in Escherichia coli to overcome this problem.

213 By performing SEER in Escherichia coli to screen hundreds of putative SSAPs, w

214 odons (CGU, CGC, and CGA) are decoded by two Escherichia coli tRNA(Arg) isoacceptors.

215 ts of transcript, protein and flux levels of Escherichia coli under various growth conditions as well

216 protein expressed in mammalian cells and in Escherichia coli using in vitro and in vivo methods.

217 The Escherichia coli Uup and RadD proteins function in diffe

218 . smegmatis, which possesses homologs of the Escherichia coli uvrA, uvrB, and uvrC genes, removes cyc

219 us with heterotrophic Escherichia coli K-12, Escherichia coli W, Yarrowia lipolytica, or Bacillus sub

220 Translocation of Escherichia coli was associated with the formation of co

221 Escherichia coli was detected as a model analyte.

222 charide synthesis, as has been suggested for Escherichia coli We find that ftsH interacts with divers

223 monas aeruginosa, Staphylococcus aureus, and Escherichia coli We have previously demonstrated that sp

224 genotypes in three distinct mRNA contexts in Escherichia coli We uncovered generic principles governi

225 Among Gram-negative bacteria, Escherichia coli were predominant.

226 by the treatment of beta-lactamase-carrying Escherichia coli with cefotaxime.

227 We experimentally evolved populations of Escherichia coli with genetically perturbed TMs for 1,00

228 from a biochemical analysis of the purified Escherichia coli YecSC-FliY cysteine/cystine import syst

229 some profiling analysis of phage T4-infected Escherichia coli yielded protected mRNA fragments within

230 OPEX-guided exploration of Escherichia coli's populations exposed to biocide and an

231 e (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacterial pathogens as well as with he

232 itive (Bacillus subtilis) and Gram-negative (Escherichia coli) targets.

233 -encoding plasmid was present in K. oxytoca, Escherichia coli, and Enterobacter cloacae isolates from

234 ium tuberculosis, Staphylococcus aureus, and Escherichia coli, and identify thousands of MGEs, includ

235 In Escherichia coli, Braun's lipoprotein (Lpp) forms the on

236 is class include M.EcoGII and M.EcoP15I from Escherichia coli, Caulobacter crescentus cell cycle-regu

237 In Escherichia coli, conditional lethality of the yggS and

238 d analysis of the three most common species, Escherichia coli, Enterococcus faecalis and Bacteroides

239 ACPs in complex with the elongating KSs from Escherichia coli, FabF and FabB, in order to better unde

240 ost well-studied of organisms, the bacterium Escherichia coli, for ~65% of promoters we remain ignora

241 Cytomegalovirus, Escherichia coli, group B Streptococcus, and other infec

242 ed from intestinal bacteria and expressed in Escherichia coli, has become commercially available.

243 ble for recycling peptidoglycan fragments in Escherichia coli, has not been annotated for most intrac

244 ine that the high-persister mutant strain of Escherichia coli, HipQ, is associated with the phenotype

245 hat is present in mycobacteria but absent in Escherichia coli, is required for the EsxA:B separation.

246 vitro antimicrobial activity of CAR against Escherichia coli, Listeria monocytogenes, Salmonella ent

247 In the Gram-negative bacterium Escherichia coli, membrane-bound sensor CusS and its res

248 ution digestions of proteomes extracted from Escherichia coli, mouse embryonic fibroblast cell cultur

249 o difference in the prevalence of pathogenic Escherichia coli, norovirus, or Giardia genes in the dom

250 ive organisms, including the human pathogens Escherichia coli, Pseudomonas aeruginosa, and Vibrio cho

251 erable 'all-in-one' vector was functional in Escherichia coli, Pseudomonas syringae and Klebsiella pn

252 AAE genes, expressed them heterologously in Escherichia coli, purified the corresponding recombinant

253 ositive blood cultures for P. aeruginosa and Escherichia coli, respectively.

254 tein HU and on the ParB partition protein in Escherichia coli, revealing partially reversible dissoci

255 Enterococcus spp., Escherichia coli, Salmonella enterica, Staphylococcus au

256 Escherichia coli, Salmonella enteritidis, Listeria innoc

257 In Escherichia coli, septal PG synthesis and cell constrict

258 e finding that commensal bacteria, including Escherichia coli, stimulated HDAC activity through metab

259 In Escherichia coli, the CTT contains a structurally flexib

260 TPS1 and with a heterologous TPS (OtsA) from Escherichia coli, under the control of the TPS1 promoter

261 tribution of the FinO-domain ProQ protein in Escherichia coli, we carried out RIL-seq to identify RNA

262 -canonical cross-links into the cell wall of Escherichia coli, we generated a bacterium where up to 3

263 tive guidelines for compound accumulation in Escherichia coli, we have converted the antibiotic Riboc

264 rary of the bla(ampC) beta-lactamase gene of Escherichia coli, we identified mutations that allow gro

265 monitoring of gene-copy-number mutations in Escherichia coli, we show that gene duplications and amp

266 By contrast, (ATP-dependent) PfkA of Escherichia coli, which does rely on transaldolase, had

267 veal an increased sensitivity also to LPS of Escherichia coli, which had no effect in WT mice.

268 In Escherichia coli, which has a type I-E system, Cas1-Cas2

269 ted, arsH1 and arsH2 genes were expressed in Escherichia coli, which has an endogenous arsRBC operon

270 into a Flux Balance Analysis (FBA) model of Escherichia coli, which quantitatively revealed potentia

271 anslocation of a gut-resident human pathogen Escherichia coli, which spreads systemically and caused

272 tive Shigella species are close relatives of Escherichia coli, yet relatively few previously describe

273 , consists of an RNA-guided Cas9 nickase, an Escherichia coli-derived uracil DNA N-glycosylase (eUNG)

274 We used a preclinical model of uropathogenic Escherichia coli-induced acute pyelonephritis to determi

275 Colicins are Escherichia coli-specific bacteriocins that translocate

276 l inflammatory profile accounted for reduced Escherichia coli-specific responses in aged MAIT cells c

277 use model of colonization resistance against Escherichia coli.

278 200 mRNAs per cell for exponentially growing Escherichia coli.

279 mental characteristic of bacteria other than Escherichia coli.

280 ast to be segregated before cell division in Escherichia coli.

281 B Streptococcus, Staphylococcus aureus, and Escherichia coli.

282 l role of ribosome recycling factor (RRF) in Escherichia coli.

283 ions on antibiotic resistance development in Escherichia coli.

284 he transcription of a Fur-controlled gene in Escherichia coli.

285 processing of the 3' end of the 16S rRNA in Escherichia coli.

286 ylanase, Xyl10E, was cloned and expressed in Escherichia coli.

287 as low a level of in vivo mistakes in RNA as Escherichia coli.

288 enomes and functionally characterize them in Escherichia coli.

289 rillum rubrum and Extraintestinal Pathogenic Escherichia coli.

290 l data of DNA polymerase I diffusing in live Escherichia coli.

291 ndCDE from Salmonella enterica and IscS from Escherichia coli.

292 with competing strains of S. Typhimurium and Escherichia coli.

293 d to enhance the antimicrobial resistance of Escherichia coli.

294 with meropenem to treat carbapenem-resistant Escherichia coli.

295 achinery that controls flagellar motility in Escherichia coli.

296 gineering of Azotobacter vinelandii NifEN in Escherichia coli.

297 Escherichia coli/pMTLacZ containing the tetracycline-med

298 e dominated by facultative anaerobic genera (Escherichia, Enterococcus, and Streptococcus), with mult

299 overall and individually at the genus level: Escherichia, Klebsiella, Enterobacter, Pseudomonas, and

300 ving potential clinical relevance, including Escherichia-Shigella linked to urinary tract infections.